Background Remission and low-disease activity are recommended targets in systemic lupus erythematosus (SLE), yet many ...
The unbridled hype of the mid-2020s is finally colliding with the structural and infrastructure limits of 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results